Skip to main content

Table 1 Baseline characteristics

From: Detection of elevated right ventricular extracellular volume in pulmonary hypertension using Accelerated and Navigator-Gated Look-Locker Imaging for Cardiac T1 Estimation (ANGIE) cardiovascular magnetic resonance

  PH (N = 12) HFrEF (N = 10) Normal (N = 10) p-value
Age (years [IQR]) 64.5 (47.5–70.5) 60.0 (53.0–65.0) 24.4 (21.7–26.3 <0.001
Gender (% female) 8 (66.7) 1 (10.0) 8 (80.0) 0.004
BMI (kg/m2 [IQR]) 25.4 (23.0–29.3) 29.2 (26.0–32.7) 24.1 (21.2–26.3) 0.47
Ischemic HD (%) 1 (8.3) 8 (80.0) 0 (0.0) <0.0001
Congenital HD (%) 1a (8.3) 1 (10.0) 0 (0.0) 1.0
DM (%) 2 (16.7) 3 (30.0) 0 (0.0) 0.23
OSA (%) 3 (25.0) 2 (20.0) 0 (0.0) 0.33
HIV (%) 2 (16.7) 0 (0.0) 0 (0.0) 0.31
CTEPH (%) 2 (16.7) 0 (0.0) 0 (0.0) 0.31
Medication-ERA 6 (50.0) 0 (0.0) 0 (0.0) 0.002
Medication-sildenafil 7 (58.3) 0 (0.0) 0 (0.0) 0.0003
Medication-PA 2 (16.7) 0 (0.0) 0 (0.0) 0.31
  1. Continuous variable are reported as median (IQR)
  2. CTEPH chronic thromboembolic pulmonary hypertension, DM diabetes mellitus, ERA endothelin receptor antagonist, HD heart disease, HIV human immunodeficiency virus, OSA obstructive sleep apnea, PA prostacyclin analogue, TE thromboembolism
  3. aThis patient has severe pulmonary hypertension resulting from late repair of a ventricular septal defect